Literature DB >> 9228548

Generation of kinins in synovial fluid from patients with arthropathy.

A P Bond1, M Lemon, P A Dieppe, K D Bhoola.   

Abstract

An enzyme-linked immunosorbent assay method is described for the measurement of kinin formation in synovial fluid from patients with rheumatoid and osteoarthritis (RA and OA). Basal kinin concentrations were less than 6 ng/ml in synovial fluid collected in the presence of inhibitors of kinin forming (kininogenase) and kinin metabolising (kininase) enzymes. During incubation of synovial fluid in the presence of kininase inhibitors alone, kinins were produced rapidly over the first 10 min, but production ceased completely within 30 min due to inhibition of the endogenous kininogenases; the rate of kinin generation during the early rapid phase correlated well with the plateau kinin concentration. Plateau kinin levels in synovial fluid from 15 patients with OA and RA ranged from 98 to 427 ng/ml, with a median value of 148 ng/ml. This study demonstrates clearly that synovial fluid from arthritis patients has the capacity to produce kinins. Although the number of patients was small, the amount of kinin generated in vitro varied over a wide range and a relationship between intra-articular kinin formation and clinical features may become apparent in a larger group of patients. The technique could also be used to investigate other biological systems in which a role has been proposed for kinins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228548     DOI: 10.1016/s0162-3109(97)00023-4

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  7 in total

1.  Role of plasma kallikrein-kinin system activation in synovial recruitment of endothelial progenitor cells in experimental arthritis.

Authors:  Jihong Dai; Alexis Agelan; Aizhen Yang; Viviana Zuluaga; Daniel Sexton; Robert W Colman; Yi Wu
Journal:  Arthritis Rheum       Date:  2012-11

2.  Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E₂ release and cyclooxygenase 2 expression in human fibroblast-like synoviocytes.

Authors:  S Meini; P Cucchi; L Tinti; S Niccolini; F Bellucci; C Catalani; C Valenti; M Galeazzi; A Fioravanti; C A Maggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-26       Impact factor: 3.000

3.  Evidence for activation of the tissue kallikrein-kinin system in nociceptive transmission and inflammatory responses of mice using a specific enzyme inhibitor.

Authors:  J A da S Emim; C Souccar; M S de A Castro; R O Godinho; M H Cezari; L Juliano; A J Lapa
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Bradykinin and B₂ receptor antagonism in rat and human articular chondrocytes.

Authors:  S Meini; P Cucchi; C Catalani; F Bellucci; S Giuliani; C A Maggi
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

5.  Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts.

Authors:  F Bellucci; P Cucchi; C Catalani; S Giuliani; S Meini; C A Maggi
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

6.  High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis.

Authors:  Reuben Gobezie; Alvin Kho; Bryan Krastins; David A Sarracino; Thomas S Thornhill; Michael Chase; Peter J Millett; David M Lee
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

7.  Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation.

Authors:  Erika Terzuoli; Stefania Meini; Paola Cucchi; Claudio Catalani; Cecilia Cialdai; Carlo Alberto Maggi; Antonio Giachetti; Marina Ziche; Sandra Donnini
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.